What's new?

Added 1 day ago Drug news

UK's MHRA has renewed for a further year the Early Access to Medicines Scheme scientific opinion for idebenone for patients with Duchenne muscular dystrophy.- Santhera

Santhera Pharmaceuticals announces that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has renewed for a further year the...

Added 1 day ago Drug news

New iclaprim data were presented at the American Society For Microbiology (ASM) Microbe 2019 meeting. Motif Bio

Motif Bio plc reported that new iclaprim data were presented at the American Society For Microbiology (ASM) Microbe 2019 meeting...

Added 9 hours ago Drug news

Opdivo in CHECKMATE 459 trial versus sorafenib in hepatocellular carcinoma fails to achieve statistical significance for overall survival.- BMS

Bristol-Myers Squibb Company announced topline results from CheckMate -459, a randomized Phase III study evaluating Opdivo (nivolumab) versus sorafenib as...

Added 9 hours ago Drug news

FDA lifts partial hold on CANOVA study of Venclexta to treat multiple myeloma.- AbbVie

AbbVie announced that the FDA has lifted the partial clinical hold placed on CANOVA (M13-494), a Phase III trial evaluating...

Added 1 day ago Drug news

FDA accepts sBLA for Baxdela to treat adult patients with community-acquired bacterial pneumonia .- Melinta Therapeutics

Melinta Therapeutics, Inc has announced the FDA has accepted a supplemental New Drug Application (sNDA) for Baxdela (delafloxacin) for priority...